×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PGEN – precigen, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PGEN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/30
07:50 am
pgen
Precigen, Inc. (NASDAQ: PGEN) had its price target raised by analysts at Cantor Fitzgerald from $7.00 to $10.00.
Medium
Report
Precigen, Inc. (NASDAQ: PGEN) had its price target raised by analysts at Cantor Fitzgerald from $7.00 to $10.00.
1/27
04:05 pm
pgen
Precigen Announces Closing of Public Offering of Common Stock
Medium
Report
Precigen Announces Closing of Public Offering of Common Stock
1/24
10:40 pm
pgen
Precigen Announces Pricing of $75.0 Million Public Offering of Common Stock
High
Report
Precigen Announces Pricing of $75.0 Million Public Offering of Common Stock
1/24
04:05 pm
pgen
Precigen Announces Proposed $75.0 Million Public Offering of Common Stock
Medium
Report
Precigen Announces Proposed $75.0 Million Public Offering of Common Stock
1/24
04:01 pm
pgen
Precigen Announces Positive Phase 1 Dose Escalation and Expansion Cohort Data for Investigational Off-the-Shelf PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis
High
Report
Precigen Announces Positive Phase 1 Dose Escalation and Expansion Cohort Data for Investigational Off-the-Shelf PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis
1/11
06:45 pm
pgen
Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference
High
Report
Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference
1/4
04:05 pm
pgen
Precigen to Host a Virtual R&D Event on January 24th to Share Safety and Efficacy Data from the Phase 1 Dose Escalation and Expansion Cohorts of PRGN-2012 AdenoVerse™ Immunotherapy in Recurrent Respiratory Papillomatosis
Neutral
Report
Precigen to Host a Virtual R&D Event on January 24th to Share Safety and Efficacy Data from the Phase 1 Dose Escalation and Expansion Cohorts of PRGN-2012 AdenoVerse™ Immunotherapy in Recurrent Respiratory Papillomatosis
12/19
04:05 pm
pgen
Precigen to Present at the 41st Annual J.P. Morgan Healthcare Conference
Neutral
Report
Precigen to Present at the 41st Annual J.P. Morgan Healthcare Conference
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/31
04:02 pm
pgen
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: KIRK RANDAL J
Medium
Report
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: KIRK RANDAL J
1/31
04:01 pm
pgen
Form SC 13D/A PRECIGEN, INC. Filed by: KIRK RANDAL J
Medium
Report
Form SC 13D/A PRECIGEN, INC. Filed by: KIRK RANDAL J
1/30
07:27 pm
pgen
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: Shah Rutul R
Low
Report
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: Shah Rutul R
1/30
07:24 pm
pgen
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: Perez Jeffrey Thomas
Low
Report
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: Perez Jeffrey Thomas
1/30
07:23 pm
pgen
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: Sabzevari Helen
Low
Report
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: Sabzevari Helen
1/30
07:19 pm
pgen
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: Thomasian Harry Jr.
Medium
Report
Form 4 PRECIGEN, INC. For: Jan 27 Filed by: Thomasian Harry Jr.
1/27
09:30 am
pgen
Form SC 13G/A PRECIGEN, INC. Filed by: Ares Trading S.A.
Low
Report
Form SC 13G/A PRECIGEN, INC. Filed by: Ares Trading S.A.
1/27
08:32 am
pgen
Form 8-K PRECIGEN, INC. For: Jan 24
Low
Report
Form 8-K PRECIGEN, INC. For: Jan 24
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Form 4 PRECIGEN, INC. For: Mar 23 Filed by: Sterling Rick L.
31.6%
4/20 Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors 20.3%
3/17 Form 4 PRECIGEN, INC. For: Mar 13 Filed by: ALVAREZ CESAR L 11.6%
3/3 Form 4 PRECIGEN, INC. For: Feb 28 Filed by: KIRK RANDAL J 8.4%
4/29 Form DEFA14A PRECIGEN, INC. 5.7%
3/1 Precigen Q4 Earnings Preview [Seeking Alpha] 3.2%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: Lehr Donald P. 2.9%
2/11 Form D PRECIGEN, INC. 1.0%
4/20 Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors 20.3%
3/17 Form 4 PRECIGEN, INC. For: Mar 13 Filed by: ALVAREZ CESAR L 11.6%
3/3 Form 4 PRECIGEN, INC. For: Feb 28 Filed by: KIRK RANDAL J 8.4%
4/29 Form DEFA14A PRECIGEN, INC. 5.7%
3/1 Precigen Q4 Earnings Preview [Seeking Alpha] 3.2%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: Lehr Donald P. 2.9%
2/11 Form D PRECIGEN, INC. 1.0%
TOP News Decliners
3/20
Form 4 PRECIGEN, INC. For: Mar 19 Filed by: KIRK RANDAL J
-22.7%
3/2 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.250 ActVsEst (0.220) - Miss -17.1%
3/10 Form 4 PRECIGEN, INC. For: Mar 08 Filed by: Turley James S -7.6%
3/17 Precigen (NASDAQ: PGEN) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.8%
2/24 Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd -4.6%
2/6 Form 8-K/A PRECIGEN, INC. For: Jan 31 -2.4%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: KIRK RANDAL J -2.4%
4/30 Precigen, Inc. (NASDAQ: PGEN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.4%
2/14 Form SC 13G PRECIGEN, INC. Filed by: MILLER VALUE PARTNERS, LLC -0.1%
3/2 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.250 ActVsEst (0.220) - Miss -17.1%
3/10 Form 4 PRECIGEN, INC. For: Mar 08 Filed by: Turley James S -7.6%
3/17 Precigen (NASDAQ: PGEN) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.8%
2/24 Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd -4.6%
2/6 Form 8-K/A PRECIGEN, INC. For: Jan 31 -2.4%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: KIRK RANDAL J -2.4%
4/30 Precigen, Inc. (NASDAQ: PGEN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.4%
2/14 Form SC 13G PRECIGEN, INC. Filed by: MILLER VALUE PARTNERS, LLC -0.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: